Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

OptimizeRx Sales Momentum Continues With Two New Enterprise-Level Engagements Added to its Digital Health Platform

OptimizeRx Corp., a leading provider of digital health solutions for life science companies and payers, has secured two new SaaS-based enterprise-level engagements that provide the full spectrum of access to the company’s nationwide digital healthcare platform.

One win represents a new platform client and the other the transition of a legacy client to the company’s new enterprise solution suite. The two deals have on average an annual contract value of $3.6 million.

“These wins demonstrate the exceptional capabilities and reach of our solutions and their proven ability to deliver value to our clients,” said OptimizeRx chief commercial officer, Steve Silvestro. “Our enterprise engagements have been producing strong results due to the improved interoperability between our point-of-care and direct-to-patient solutions, with this all working together to deliver better outcomes for patients.

Recommended AI News: VOXOX Launches The Comeback Small Business Radio Show

“As pharma continues to see restricted travel and limited patient access to healthcare providers due to COVID-19, our platform has become a ‘must-have’ solution for maintaining the flow of critical communications between industry and healthcare providers regardless of location.”

Related Posts
1 of 33,462

OptimizeRx’s newly integrated digital health platform enables unprecedented transparency into patient medication behavior, and provides access to patient-provider-pharma communications across the care continuum and in a variety of care settings. By improving these communications, pharmaceutical companies, healthcare providers and payers can more efficiently and effectively address patient medication affordability and therapeutic adherence.

Recommended AI News: Sage X3 V2020 R2 Released In India To Enable Indian Pharma Companies

OptimizeRx CEO, William Febbo, commented: “We are encouraged by the continued conversion of our pipeline of enterprise-level opportunities and the resulting buildup in recurring revenue. As these more expansive enterprise deployments better address the need for greater digital connectivity, they also provide us more revenue per customer and a more consistent revenue stream.”

“Our up-sell opportunity for converting just our legacy clients from individual solutions to enterprise platform engagements remains greater than $100 million,” added Febbo. “While naturally this will not be realized overnight, these two wins, making it six in total so far in 2020, demonstrate the strength of our new sales team and solid results from our integrated platform approach.”

Recommended AI News: Myriad Announces Partnership With OptraHEALTH To Deliver “Gene” AI Based Information Tool

Comments are closed, but trackbacks and pingbacks are open.